
Loading, please wait...

Loading, please wait...

In a notable legal development, the Delhi High Court has directed the Food Safety and Standards Authority of India to temporarily hold off on cancelling the food business licence of FMCG major ITC Limited. This dispute centers around contentious FSSAI food labelling claims involving absolute declarations like '100% Atta' on packaged products. Justice Swarana Kanta Sharma issued a formal notice to the regulator while granting interim relief until the next scheduled hearing on September 9. Consequently, this intervention highlights essential regulatory and clinical discussions regarding consumer transparency, food marketing integrity, and public health nutrition.
The current legal confrontation stems from a regulatory advisory issued by the food authority on May 28, 2025. Through this directive, the regulator instructed all food business operators across the country to discontinue using absolute terms like '100%' on packaging, labels, and promotional material. Officials argued that such declarations are not formally defined under the statutory framework. Therefore, these claims could easily mislead everyday consumers by implying unmatched superiority or complete purity.
Following this advisory, authorities issued a show-cause notice to ITC on August 10, alleging non-compliance regarding its Aashirvaad Shudh Chakki Atta packaging. Although the initial notice granted thirty days for a response, an improvement notice followed shortly on August 13. This subsequent directive demanded label modifications within fifteen days. ITC promptly challenged these administrative actions in court. The company asserted that enforcing punitive measures before evaluating its formal clarification violated natural justice. Furthermore, ITC argued that the regulator exceeded its statutory mandate by attempting to enforce a non-binding advisory without enacting formal legislative amendments under the Food Safety and Standards Act of 2006.
ITC presented detailed legal arguments to defend its brand packaging and commercial rights. The company contended that existing food safety regulations do not expressly prohibit the truthful use of percentage descriptors. Specifically, the petitioner cited Regulation 4(4) of the Food Safety and Standards (Labelling and Display) Regulations, 2020. This statutory provision permits manufacturers to provide informative descriptors on packaging, provided that the data does not contradict established standards.
In addition, the enterprise referenced the Food Safety and Standards (Advertising and Claims) Regulations of 2018. The company emphasized that its packaging accurately informs buyers that the product comprises whole wheat flour rather than refined flour mixtures. Conversely, the regulator argued that absolute marketing claims create an unverified impression of perfection. FSSAI maintained that such phrases could undermine compliant competitors and confuse consumers. During initial court proceedings, the food authority also challenged the jurisdiction of the Delhi High Court. Consequently, the bench directed both parties to submit concise written submissions regarding territorial jurisdiction before substantive arguments commence.
For medical practitioners, dietitians, and public health professionals, accurate packaging statements represent crucial clinical tools. Clinicians frequently advise individuals managing lifestyle conditions, such as diabetes, hypertension, and obesity, to carefully review ingredient lists. When packaged staples carry prominent declarations of absolute purity, patients often assume the product offers unique therapeutic advantages. Consequently, patients may consume larger portion sizes without understanding overall caloric density or glycemic impact.
Moreover, physicians must often navigate dietary misconceptions during routine clinical consultations. Patients frequently equate marketing terms such as '100% whole grain' or 'pure' with uncompromised therapeutic safety. While whole wheat flour undoubtedly provides superior dietary fiber compared to refined wheat flour, total carbohydrate intake still requires diligent monitoring in metabolic disorders. Clear, unambiguous food labels enable doctors and clinical nutritionists to prescribe specific dietary regimens with confidence. When packaging claims blur the line between verified composition and promotional hyperbole, patients struggle to maintain evidence-based dietary compliance, which directly affects chronic disease management.
From a wider public health perspective, food packaging directly shapes household purchasing patterns. Packaged wheat flour serves as a primary source of complex carbohydrates and dietary fiber across millions of Indian households. Therefore, absolute claims prominently printed on packaging wield significant psychological influence over purchasing decisions. Consumers naturally gravitate toward products that project complete purity, especially when caring for vulnerable family members like children and elderly relatives.
However, public health experts emphasize that marketing terms should never substitute for transparent nutritional panels. When manufacturers use bold percentage claims, consumers often overlook detailed information regarding added micro-nutrients, processing methods, or sodium content. Regulatory bodies worldwide consistently strive to ensure that packaging remains informative rather than persuasive. By enforcing uniform standards across all food categories, authorities protect consumers from exaggerated commercial declarations. This consistent regulatory oversight ensures that household food choices reflect verified nutritional facts rather than subjective advertising strategies, ultimately strengthening preventative health initiatives nationwide.
The ongoing legal discourse between regulatory authorities and food manufacturers highlights the urgent need for harmonized labelling standards. In recent months, several prominent brands have voluntarily altered packaging to remove absolute percentage declarations, including terms on honey, cooking oils, and snack items. These widespread packaging revisions signal a structural shift toward stricter marketing accountability across the entire FMCG landscape.
Moving forward, healthcare providers must stay informed about evolving food safety directives. Doctors and nutritionists should proactively educate patients on interpreting comprehensive nutrition labels rather than relying solely on front-of-pack claims. Patients should learn to scrutinize ingredient lists, serving sizes, and macronutrient breakdowns. As judicial institutions and regulatory bodies establish clearer legal boundaries, standardized food labelling will ultimately empower consumers and clinical teams to make sound, health-conscious dietary choices.
Q1: Why did the Delhi High Court pause regulatory action against ITC?
The Delhi High Court directed the regulator to hold off on licence cancellation because the bench needs to decide preliminary jurisdictional issues and review the legality of the underlying regulatory advisory during the upcoming hearing on September 9.
Q2: Why does the food safety authority restrict 100 percent claims on food packaging?
The regulator restricts absolute percentage claims because they are undefined under statutory regulations and can mislead consumers into believing a commercial product possesses absolute purity, perfection, or unmatched superiority over competing compliant goods.
Q3: How do food labelling disputes impact clinical practice and patient guidance?
Labelling disputes directly affect clinical practice because healthcare providers rely on accurate product descriptions to guide patient diets. Clear packaging ensures patients make informed choices regarding carbohydrate intake, fiber content, and metabolic health management.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Delhi High Court has directed the Food Safety and Standards Authority of India to pause regulatory action against ITC Limited regarding '100%' packaging claims on Aashirvaad Atta. This interim directive underscores critical discussions surrounding food labelling regulations, consumer perception, and dietary guidance.
Today

A landmark global analysis reveals that fine particulate matter (PM2.5) represents the leading environmental driver of cancer incidence worldwide. Emerging evidence indicates that chronic exposure elevates systemic oncogenesis across respiratory, reproductive, endocrine, and urinary organ systems.
Today

The NICE framework introduces a two-step non-invasive approach combining DECENT-plus computational purification and machine learning to analyze embryo cfDNA from spent culture medium, overcoming maternal contamination and enabling accurate embryo prioritization in assisted reproductive technology.
Today

As ultra-processed food consumption surges, India's food regulator faces intense judicial scrutiny from the Supreme Court over delayed front-of-pack warning labels. Discover how industry resistance, dual product formulation standards, and public health demands shape this critical cardiometabolic debate.
Today

Kedaara Capital has acquired a 51% majority stake in Tynor Orthotics for $200 million. The landmark investment aims to scale domestic manufacturing, accelerate research and development, and expand distribution of high-quality orthopaedic supports and mobility aids across domestic and global healthcare markets.
Today

Elevated serum uric acid in psoriasis significantly reduces clinical response rates to ixekizumab, an IL-17A inhibitor. A multicenter cohort study reveals strong links between hyperuricemia, cardiometabolic risk, and circulating inflammatory proteins, underscoring the need for integrated metabolic management.
Today